Rohto Pharmaceutical Co.,Ltd.
RPHCF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $526,247 | $77,161,000 | $392,495 | $64,502,000 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $461,561 | $47,129,000 | $469,877 | $48,694,000 |
| Inventory | $438,288 | $61,580,000 | $389,582 | $61,859,000 |
| Other Curr. Assets | $66,323 | $32,009,000 | $54,677 | $29,840,000 |
| Total Curr. Assets | $1,492,419 | $217,879,000 | $1,306,630 | $204,895,000 |
| Property Plant & Equip (Net) | $613,158 | $90,451,000 | $552,201 | $88,524,000 |
| Goodwill | $228,515 | $47,494,000 | $292,668 | $49,531,000 |
| Intangibles | $240,929 | $8,575,000 | $54,308 | $8,437,000 |
| Long-Term Investments | $322,421 | $0 | $305,770 | $0 |
| Tax Assets | $0 | $3,975,000 | $0 | $0 |
| Other NC Assets | $74,712 | $53,497,000 | $56,967 | $56,871,000 |
| Total NC Assets | $1,479,735 | $203,992,000 | $1,261,913 | $203,363,000 |
| Other Assets | $0 | $4,000 | $0 | $2,000 |
| Total Assets | $2,972,154 | $421,875,000 | $2,568,543 | $408,260,000 |
| Liabilities | – | – | – | – |
| Payables | $167,216 | $19,050,000 | $152,195 | $20,001,000 |
| Short-Term Debt | $47,484 | $7,035,000 | $133,674 | $24,300,000 |
| Tax Payable | $0 | $6,963,000 | $0 | $5,620,000 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $373,998 | $61,560,000 | $392,565 | $61,225,000 |
| Total Curr. Liab. | $588,698 | $94,608,000 | $678,434 | $111,146,000 |
| LT Debt | $291,709 | $43,188,000 | $113,132 | $20,236,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $2,081,000 | $0 | $0 |
| Other NC Liab. | $120,031 | $10,560,000 | $77,706 | $12,534,000 |
| Total NC Liab. | $411,739 | $55,829,000 | $190,838 | $32,770,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,000,437 | $150,437,000 | $869,272 | $143,916,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $45,131 | $6,504,000 | $41,365 | $6,504,000 |
| Retained Earnings | $1,657,526 | $228,442,000 | $1,411,812 | $214,342,000 |
| AOCI | $217,212 | $0 | $206,827 | $0 |
| Other Equity | -$68,939 | $25,147,000 | -$31,393 | $32,193,000 |
| Total Equity | $1,850,930 | $260,093,000 | $1,628,612 | $253,039,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $120,766 | $11,345,000 | $70,647 | $11,305,000 |
| Total Liab. & Tot. Equity | $2,972,133 | $421,875,000 | $2,568,531 | $408,260,000 |
| Net Debt | -$187,055 | -$26,938,000 | -$145,689 | -$19,966,000 |